Risk factors

Clinical, regulatory, safety, and reimbursement risks could prevent oncology medicines from reaching or expanding in the market.

Acadian Asset Management depends heavily on operating subsidiary Acadian LLC for cash flows and revenue generation.

Concentration of operations in a single Tulsa, Oklahoma facility increases natural disaster vulnerability. Reliance on third-party representatives to market HVAC products creates distribution risks. Exposure to raw material price volatility in steel, copper, and aluminum impacts manufacturing costs.

AbCellera relies heavily on unproven antibody discovery platforms and early-stage therapeutics pipelines with no commercial products yet.

Acacia depends heavily on commercializing NUPLAZID and DAYBUE and obtaining approvals for trofinetide in the EU and outside North America. The company faces high clinical trial failure risks, heavy reliance on third-party manufacturers like Patheon, and accumulated net losses of approximately $2.2 billion.

Arch Capital faces primary risks from global insurance market competition, cyclical premium rate fluctuations, and catastrophic weather event losses. Mortgage insurance operations depend heavily on GSE requirements, low down payment volumes, and government competition like the FHA. The company is exposed to evolving global climate regulations, cybersecurity threats, and international trade sanctions.

Behavioral healthcare provider faces heavy federal and state regulatory burdens, government reimbursement dependence, and litigation risks.

This is an initial filing with no prior year comparison available.

Aclaris Therapeutics relies heavily on external partners to develop and commercialize its preclinical and clinical-stage drug candidates. The company faces a substantial accumulated deficit of $902.9 million and requires significant additional capital. Patent protection and complex regulatory pathways heavily dictate the viability of its kinase inhibitor and biologic pipeline.

ADT faces intense competition across DIFM and DIY security markets and high customer acquisition costs requiring long retention periods.

Airgain faces ongoing net losses, with an accumulated deficit of $87.2 million as of December 31, 2024. A heavy customer concentration exists, with top customers generating 54% of sales. The company relies heavily on outsourced contract manufacturers and ODMs for production.

Infrastructure maintenance, vegetation management, and agriculture markets drive our business demand.